US drugmaker Merck has applied to the US Federal Food and Drug Administration for emergency use approval of its drug Molnupiravir, which was developed against the coronavirus.
US drugmaker Merck and its partner, Ridgeback Biotherapeutic, have filed an application with the US Federal Food and Drug Administration (FDA) for the drug to be used in pill form.
This reduces the effects of coronavirus and virus-related death rates, especially for coronavirus patients who are at risk of hospitalization and death.
The Food and Drug Administration, expected to announce its decision within a week, will examine data on the safety and efficacy of molnopiravir.
If the drug is approved by the Food and Drug Administration, it will be the first oral antiviral drug used to treat coronavirus.
Merck announced on October 1 that it had developed the first drug in pill form that reduces the effects of the coronavirus and the death rates associated with the virus.